Syngene International appoints Dr Rohtash Kumar as Head of CDMO, Small and Large Molecule

Written By :  Ruchika Sharma
Published On 2025-11-19 08:45 GMT   |   Update On 2025-11-19 08:45 GMT
Advertisement

Karnataka: Syngene International has announced the appointment of Dr Rohtash Kumar as Head of CDMO, Small and Large Molecule and a member of the Executive Committee (Senior Management Personnel) of the Company, with effect from December 1, 2025.

Rohtash is an established pharmaceutical operations leader with over two decades of experience in R&D, manufacturing, and executive leadership across global CDMO organizations. Most recently, he led Global Technology and Development at Veranova, where he drove innovation in APIs, including small molecules, peptides, oligonucleotides, and biologics. His efforts successfully advanced branded API molecules to market in collaboration with biotech partners. He also worked at 
Advertisement
Bachem Americas, Inc., Sigma-Aldrich, Toronto Research Chemicals, and Apotex Inc.
A prolific researcher, Rohtash holds multiple patents and publications to his name. He earned his Ph.D. in Organic Chemistry from the University of Delhi, an M.Sc. in Organic Chemistry, and an MBA from Chaudhary Charan Singh University. Additionally, he is a member of the American, Canadian, and Indian Medical Societies.

Read also: Syngene International ropes in Surender Sharma as General Counsel, Executive Committee member

Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.

Read also: Syngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates development

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News